LPL and hyperinsulinemic hypoglycemia, familial, 4: Glybera (alipogene tiparvovec), a gene therapy product that replaces the LPL gene is available in Europe from uniQure (www.uniqure.com) for the treatment of patients diagno244sed with a genetic deficiency in familial lipoprotein lipase disease (LPLD).